[Results in the use of blood components separated by cytophoresis in leukemia treated with cytostatics (our 1st experiences with flowing-effect centrifuge)].
Since the essence of the malign process is still unknown, together with the basic causal principle (or principles?) of the pathological, malign growth, we, are not in position to apply the adequate, the only correct causal therapy with leukosis. As a consequence, we have numberous therapeutical diagrams with leukosis. As a consequence, we have numerous therapeutical diagrams in which there is adomination of pharmacological substances having cytostatic effects of anti-microbal, substitutional and symptomatical therapies. Cytostatics represent an expressedly different therapy. Various, very powerful cytostatic combinations and procedures applied with a desire to bring the patient into remission often cause the therapeutist to have another, very important problem: how to prevent the haematological complications using the cytostatic therapy, primarily the leukopenia and thrombocytopenia which, in bodies damaged by malign processes, can cause difficult complications. In order to avoid these, a series of new methods have been developed within the cytophoresis and haemotherapy. With the advent of separators of blood components it seems that the problem of selective and precise haemotherapy has been solved completely. Namely, if the components are applied precisely, in the stage when the patient lacks them in the desired concentration, the possibility of manifold therapeutical applications offer a possibility for an adequate subtitutional therapy. This paper brings forward our initial results from this field. The CENTRIFUGE-- AMINCO was used for seperation. The seperation in it takes place in a closed system (infection impossible), and thanks to special construction which simulates the internal medium of blood vessels, the mechanical decay of tangible components in the extracorporal medium has been reduced to a minimum. By means of adjustment of peristaltic pumps, the desired seperation is possible to be achieved. Concentrated components obtained by means of separation (leukocytes and thrombocytes, separated or together), have been applied with patients having leukosis once or several times, in the stage when they, due to cytostatic treatment, had very low values of these components with the existing or threatening complications. The substitional therapy has been applied with 14 patients and very efficient effects have been observed.